Harwin Peter Evan
CIK 1663607
Transactions on file
14
Open-market buys
3
Win rate (buys)
33%
3 scored
Avg % since filing (buys)
+5.7%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-03 | APGE Apogee Therapeutics, Inc. | Director | Disp. | 51,166 | $0.00 | — | open → |
| 2026-09-03 | 2026-09-03 | APGE Apogee Therapeutics, Inc. | Director | Disp. | 51,166 | $0.00 | — | open → |
| 2026-09-03 | 2026-09-03 | APGE Apogee Therapeutics, Inc. | Director | Disp. | 340,855 | $0.00 | — | open → |
| 2026-08-11 | 2026-08-07 | APGE Apogee Therapeutics, Inc. | Director | Exer. | 10,370 | $454.7K | +208.0% | open → |
| 2026-08-11 | 2026-08-07 | APGE Apogee Therapeutics, Inc. | Director | Exer. | 31,838 | $541.2K | +694.5% | open → |
| 2026-07-20 | 2026-07-16 | CBIO CRESCENT BIOPHARMA, INC. | Director10% | Buy | 853,450 | $12.38M | -18.3% | open → |
| 2026-07-02 | 2026-07-01 | ORKA Oruka Therapeutics, Inc. | Director10% | Sale | 3,553,410 | $300.01M | -5.1% | open → |
| 2026-07-02 | 2026-07-01 | ORKA Oruka Therapeutics, Inc. | Director10% | C | 3,553,410 | $0.00 | — | open → |
| 2026-06-24 | 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Director | Sale | 4,684,781 | $399.66M | +5.9% | open → |
| 2026-06-24 | 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Director | C | 666,680 | $0.00 | — | open → |
| 2025-12-08 | 2025-12-04 | CBIO CRESCENT BIOPHARMA, INC. | Director10% | Buy | 1,360,000 | $18.24M | -11.7% | open → |
| 2025-10-09 | 2025-10-07 | ZBIO Zenas BioPharma, Inc. | Director | Buy | 316,219 | $6.01M | +47.1% | open → |
| 2025-10-08 | 2025-10-06 | JBIO Jade Biosciences, Inc. | Director10% | Grant | 1,333,126 | $12.18M | +119.7% | open → |
| 2025-09-19 | 2025-09-17 | ORKA Oruka Therapeutics, Inc. | Director10% | Grant | 333,340 | $5.00M | +434.3% | open → |
